PULMONARY FIBROSIS FOUNDATION: Form 990, tax year 2020

View the entire original 990 at ProPublica ↗

Organization
PULMONARY FIBROSIS FOUNDATION (EIN 84-1558631)
Tax period
2020-07-01 to 2021-06-30
Filed
2022-04-25
IRS object ID
202241159349301359
Schema version
2020v4.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2022-04-25T15:59:41-05:00ReturnTs
Tax Period End2021-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1BDO USA LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line19500 Bryn Mawr Ave Suite 300AddressLine1Txt
CityRosemontCityNm
State AbbreviationILStateAbbreviationCd
ZIP60018ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2020-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN841558631EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Pulmonary Fibrosis FoundationBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% SCOTT STASZAK COOInCareOfNm
Business Name ControlPULMBusinessNameControlTxt
Phone3122652182PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 East Ohio Street Suite 500AddressLine1Txt
CityChicagoCityNm
State AbbreviationILStateAbbreviationCd
ZIP606113270ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonScott StaszakPersonNm
Person TitleCOOPersonTitleTxt
Phone3125879272PhoneNum
Signature2022-04-20SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstScottPersonFirstNm
Person LastStaszakPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJACOB COOKPreparerPersonNm
PTINP01240455PTIN
Phone8476762000PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
FieldValueIRS element (for citing)
Tax2020TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerScott StaszakPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 E Ohio Street Suite 500AddressLine1Txt
CityChicagoCityNm
State AbbreviationILStateAbbreviationCd
ZIP606113270ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$10,094,902GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.pulmonaryfibrosis.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2000FormationYr
Legal Domicile StateCOLegalDomicileStateCd
Activity Or MissionTo mobilize people and resources to provide access to high-quality care and lead research for a cure so that people with pulmonary fibrosis will live longer, healthier lives.ActivityOrMissionDesc
Voting Members Governing Body15VotingMembersGoverningBodyCnt
Voting Members Independent15VotingMembersIndependentCnt
Total Employee39TotalEmployeeCnt
Total Volunteers1899TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$8,450,064PYContributionsGrantsAmt
CY Contributions Grants$6,636,670CYContributionsGrantsAmt
PY Program Service Revenue$2,548,146PYProgramServiceRevenueAmt
CY Program Service Revenue$2,908,697CYProgramServiceRevenueAmt
PY Investment Income$293,084PYInvestmentIncomeAmt
CY Investment Income$65,617CYInvestmentIncomeAmt
PY Other Revenue-$589,250PYOtherRevenueAmt
CY Other Revenue-$645,389CYOtherRevenueAmt
PY Total Revenue$10,702,044PYTotalRevenueAmt
CY Total Revenue$8,965,595CYTotalRevenueAmt
PY Grants And Similar Paid$342,863PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$302,895CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$3,557,722PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$3,807,101CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,046,077CYTotalFundraisingExpenseAmt
PY Other Expenses$7,391,038PYOtherExpensesAmt
CY Other Expenses$4,231,849CYOtherExpensesAmt
PY Total Expenses$11,291,623PYTotalExpensesAmt
CY Total Expenses$8,341,845CYTotalExpensesAmt
PY Revenues Less Expenses-$589,579PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$623,750CYRevenuesLessExpensesAmt
Total Assets BOY$10,892,804TotalAssetsBOYAmt
Total Assets EOY$14,745,592TotalAssetsEOYAmt
Total Liabilities BOY$3,594,974TotalLiabilitiesBOYAmt
Total Liabilities EOY$5,433,309TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$7,297,830NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$9,312,283NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTO MOBILIZE PEOPLE AND RESOURCES TO PROVIDE ACCESS TO HIGH-QUALITY CARE AND LEAD RESEARCH FOR A CURE SO THAT PEOPLE WITH PULMONARY FIBROSIS WILL LIVE LONGER, HEALTHIER LIVES.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$2,095,135ExpenseAmt
Grant$0GrantAmt
Revenue$2,214,951RevenueAmt
DescPFF PATIENT REGISTRY: TOTAL REVENUE RECOGNIZED FOR THE PROGRAM WAS $2,910,419 WHICH INCLUDED CONTRIBUTIONS AND SPONSORSHIPS OF $695,468 IN ADDITION TO THE PROGRAM SERVICE REVENUE OF $2,214,951. THE PFF REGISTRY (REGISTRY) IS A RESEARCH EFFORT THAT BRINGS TOGETHER MULTIPLE STAKEHOLDERS INCLUDING PATIENTS, HEALTH CARE PROVIDERS, AND RESEARCHERS TO ADVANCE RESEARCH AND IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH PULMONARY FIBROSIS (PF). THE CRUX OF THE REGISTRY IS COMPRISED OF AN ELECTRONIC DATABASE OF PATIENT INFORMATION ON DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE THAT IS DE-IDENTIFIED (MADE ANONYMOUS) AND (CONTINUED ON SCHEDULE O)Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,211,362ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescEDUCATION: TOTAL REVENUE RECOGNIZED FOR EDUCATION WAS $782,495 WHICH INCLUDED $208,539 IN CONTRIBUTIONS AND SPONSORSHIPS RECEIVED DURING THE YEAR OR RELEASED FROM PRIOR YEAR RECEIPTS. THE PULMONARY FIBROSIS FOUNDATION (PFF) IS COMMITTED TO PROVIDING QUALITY DISEASE EDUCATION TO THE PULMONARY FIBROSIS COMMUNITY. THE PFF STRIVES TO PROVIDE PATIENTS, CAREGIVERS, FAMILY MEMBERS, AND HEALTH CARE PROVIDERS WITH THE RESOURCES NECESSARY TO MORE FULLY UNDERSTAND PF, AND TO PROVIDE PATIENTS WITH THE TOOLS NECESSARY TO LIVE WITH THE DISEASE AND IMPROVE THEIR QUALITY OF LIFE. (CONTINUED ON SCHEDULE O)Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$621,082ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescPROGRAM SUPPORT: TOTAL REVENUE RECOGNIZED FOR THE PROGRAM SUPPORT WAS $175,000 WHICH INCLUDED $15,129 IN CONTRIBUTIONS AND SPONSORSHIPS RECEIVED DURING THE YEAR OR RELEASED FROM PRIOR YEAR RECEIPTS. WE BEGAN THE FISCAL YEAR BY DEVELOPING A NEW BRAND IDENTITY FOR THE PFF. THE NEW LOGO MARK IS ATTENTION-GETTING, EASY TO UNDERSTAND, AND MEMORABLE. IT IS BASED ON TWO HUMAN LUNGS AND PROMOTES MODERNITY, POSITIVITY, AND FORWARD-THINKING. IN NOVEMBER, WE RELAUNCHED OUR PUBLIC AWARENESS CAMPAIGN WITH A NEW THEME AND LOGO ENTITLED "PINPOINT PF" TO ENCOURAGE AT-RISK PATIENTS, CAREGIVERS, (CONTINUED ON SCHEDULE O)Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$2,061,192TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$302,895TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$693,746TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$5,988,771TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsfalseDonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesfalseForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContrifalseDeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document27IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee39EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members15GoverningBodyVotingMembersCnt
Independent Voting Member15IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonSCOTT STASZAK COOPersonNm
Phone3122652182PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 EAST OHIO STREET SUITE 500AddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP60611ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (21 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
William T Schmidt
Director/President and CEO40.00.0Yes (X)$282,100$0$28,500
Scott Staszak
Chief Operating Officer40.00.0Yes (X)$212,987$0$26,000
Laura Sadler
Chief Marketing Officer40.00.0$186,056$0$6,794Yes (X)
Seth Klein
SENIOR VP, DEVELOPMENT40.00.0$153,934$0$12,781Yes (X)
Kathryn TREBONSKY
VP, FINANCE THRU 04/01/2140.00.0$135,889$0$26,648Yes (X)
Zoe Bubany
VP, Board & External Relations40.00.0$121,221$0$10,379Yes (X)
George Eliades
Chairman1.00.0Yes (X)$0$0$0Yes (X)
David McNinch
Vice-Chair1.00.0Yes (X)$0$0$0Yes (X)
Laurie Chandler CFP
Treasurer1.00.0Yes (X)$0$0$0Yes (X)
Terence Hales
Secretary1.00.0Yes (X)$0$0$0Yes (X)
Martin Attwell
Director1.00.0$0$0$0Yes (X)
Dana A Ball
Director1.00.0$0$0$0Yes (X)
Julie Halston
Director1.00.0$0$0$0Yes (X)
Jeff Harris
Director1.00.0$0$0$0Yes (X)
Mike Henderson
Director1.00.0$0$0$0Yes (X)
Susan Jacobs
Director1.00.0$0$0$0Yes (X)
PJ Kamani
Director1.00.0$0$0$0Yes (X)
Andy Limper
Director1.00.0$0$0$0Yes (X)
Barbara Murphy
Director1.00.0$0$0$0Yes (X)
Patricia Rosa
Director1.00.0$0$0$0Yes (X)
Bill Schmidt
Director1.00.0$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,092,187TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$111,102TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K6IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (3 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
LC Williams Associates
150 N Michigan Ave Ste 3800CHICAGOIL60601Public Relations$429,175
Dorothy Coyle Raclaw
5855 N Kenneth AveCHICAGOIL60646Marketing Consulting$136,825
HCM Strategies LLC
1156 15th Street NW Ste 850WASHINGTONDC20005Advocacy Consulting$130,000
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K3CntrctRcvdGreaterThan100KCnt
Fundraising$1,038,876FundraisingAmt
Government Grants$560,300GovernmentGrantsAmt
All Other Contributions$5,037,494AllOtherContributionsAmt
Noncash Contributions$6,721NoncashContributionsAmt
Total Contributions$6,636,670TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
PFF PATIENT REGISTRY900099$2,214,951$2,214,951
CORP PARTNERSHIPS900099$693,746$693,746
FieldValueIRS element (for citing)
Total Program Service Revenue$2,908,697TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$152,919TotalRevenueColumnAmt
Exclusion$152,919ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$372,816SecuritiesAmt
Other$151OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$434,797SecuritiesAmt
Other$25,472OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$61,981SecuritiesAmt
Other-$25,321OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$87,302TotalRevenueColumnAmt
Exclusion-$87,302ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,038,876ContriRptFundraisingEventAmt
Fundraising Direct Expenses$538,529FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$538,529TotalRevenueColumnAmt
Exclusion-$538,529ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$10,784GrossSalesOfInventoryAmt
Cost Of Goods Sold$130,509CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column-$119,725TotalRevenueColumnAmt
Exclusion-$119,725ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
UBIT REFUND900099$11,461$11,461
INTEREST REFUND900099$1,404$1,404
FieldValueIRS element (for citing)
Other Revenue Total$12,865OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$8,965,595TotalRevenueColumnAmt
Related Or Exempt Func Income$2,908,697RelatedOrExemptFuncIncomeAmt
Exclusion-$579,772ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$302,895TotalAmt
Program Services$302,895ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$909,868TotalAmt
Program Services$556,639ProgramServicesAmt
Management And General$85,478ManagementAndGeneralAmt
Fundraising$267,751FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$2,464,251TotalAmt
Program Services$1,315,096ProgramServicesAmt
Management And General$697,316ManagementAndGeneralAmt
Fundraising$451,839FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$65,623TotalAmt
Program Services$37,239ProgramServicesAmt
Management And General$15,697ManagementAndGeneralAmt
Fundraising$12,687FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$185,817TotalAmt
Program Services$74,338ProgramServicesAmt
Management And General$76,893ManagementAndGeneralAmt
Fundraising$34,586FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$181,542TotalAmt
Program Services$105,861ProgramServicesAmt
Management And General$39,525ManagementAndGeneralAmt
Fundraising$36,156FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$59,068TotalAmt
Management And General$59,068ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$31,327TotalAmt
Management And General$31,327ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$198,656TotalAmt
Program Services$198,656ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$23,202TotalAmt
Management And General$23,202ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$2,920,015TotalAmt
Program Services$2,688,092ProgramServicesAmt
Management And General$172,597ManagementAndGeneralAmt
Fundraising$59,326FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$117,996TotalAmt
Program Services$117,996ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$227,012TotalAmt
Program Services$150,087ProgramServicesAmt
Management And General$15,241ManagementAndGeneralAmt
Fundraising$61,684FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$12,660TotalAmt
Program Services$7,475ProgramServicesAmt
Management And General$2,539ManagementAndGeneralAmt
Fundraising$2,646FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$223,064TotalAmt
Program Services$130,881ProgramServicesAmt
Management And General$45,851ManagementAndGeneralAmt
Fundraising$46,332FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$5,926TotalAmt
Program Services$2,196ProgramServicesAmt
Management And General$3,633ManagementAndGeneralAmt
Fundraising$97FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$4,510TotalAmt
Program Services$2,681ProgramServicesAmt
Management And General$896ManagementAndGeneralAmt
Fundraising$933FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$61,587TotalAmt
Program Services$48,438ProgramServicesAmt
Management And General$6,439ManagementAndGeneralAmt
Fundraising$6,710FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$36,244TotalAmt
Program Services$20,469ProgramServicesAmt
Management And General$8,529ManagementAndGeneralAmt
Fundraising$7,246FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
EVENT EXPENSE - AUDIO VISUAL$97,911$96,654$257$1,000
SOFTWARE SUBSCRIPTIONS - SAAS$89,269$60,234$414$28,621
ALLOCATED SOFTWARE SUBS$75,006$44,900$10,490$19,616
DUES/SUBSCRIPTIONS/REGISTRAT$33,602$22,422$9,411$1,769

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$14,794TotalAmt
Program Services$5,522ProgramServicesAmt
Management And General$2,194ManagementAndGeneralAmt
Fundraising$7,078FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$8,341,845TotalAmt
Program Services$5,988,771ProgramServicesAmt
Management And General$1,306,997ManagementAndGeneralAmt
Fundraising$1,046,077FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$483,720BOYAmt
EOY$537,465EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$4,670,786BOYAmt
EOY$5,853,121EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$55,718BOYAmt
EOY$58,296EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$33,997BOYAmt
EOY$1,503,472EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$137,343BOYAmt
EOY$507,279EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$221,720LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$176,349LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$42,990BOYAmt
EOY$45,371EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$4,863,723BOYAmt
EOY$5,549,485EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$172,896BOYAmt
EOY$259,472EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$431,631BOYAmt
EOY$431,631EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$10,892,804BOYAmt
EOY$14,745,592EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,523,757BOYAmt
EOY$2,077,344EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$300,000BOYAmt
EOY$337,500EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$1,207,629BOYAmt
EOY$2,437,790EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$560,300BOYAmt
EOY$580,675EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$3,288BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$3,594,974BOYAmt
EOY$5,433,309EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$4,012,393BOYAmt
EOY$6,584,930EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,285,437BOYAmt
EOY$2,727,353EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$7,297,830BOYAmt
EOY$9,312,283EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,892,804BOYAmt
EOY$14,745,592EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$623,750ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$640,807NetUnrlzdGainsLossesInvstAmt
Prior Period Adjustments$749,896PriorPeriodAdjustmentsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,775,504CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,989,047CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$8,449,631CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,450,064CurrentTaxYearMinus1YearAmt
Current Tax Year$6,636,670CurrentTaxYearAmt
Total$35,300,916TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,775,504CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,989,047CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$8,449,631CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,450,064CurrentTaxYearMinus1YearAmt
Current Tax Year$6,636,670CurrentTaxYearAmt
Total$35,300,916TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$13,670,470SubstantialContributorsTotAmt
Public Support Total170$21,630,446PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$11,635CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$69,969CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$273,967CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$257,033CurrentTaxYearMinus1YearAmt
Current Tax Year$152,919CurrentTaxYearAmt
Total$765,523TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,060CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$691CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$234CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2CurrentTaxYearMinus1YearAmt
Current Tax Year$12,865CurrentTaxYearAmt
Total$14,852TotalAmt
FieldValueIRS element (for citing)
Total Support$36,081,291TotalSupportAmt
Gross Receipts Rltd Activities$13,473,417GrossReceiptsRltdActivitiesAmt
Public Support CY1700.59949PublicSupportCY170Pct
Public Support PY1700.56411PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$37,091FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$161,564FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$198,655FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,790,116FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,988,771FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$449,439FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$112,360FilingOrganizationsTotalAmt
FieldValueIRS element (for citing)
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$456,061CurrentYearMinus3Amt
Current Year Minus2$466,993CurrentYearMinus2Amt
Current Year Minus1$602,580CurrentYearMinus1Amt
Current Year$449,439CurrentYearAmt
Total$1,975,073TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$2,962,610LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$21,008CurrentYearMinus3Amt
Current Year Minus2$79,435CurrentYearMinus2Amt
Current Year Minus1$280,017CurrentYearMinus1Amt
Current Year$198,655CurrentYearAmt
Total$579,115TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$114,015CurrentYearMinus3Amt
Current Year Minus2$116,748CurrentYearMinus2Amt
Current Year Minus1$150,645CurrentYearMinus1Amt
Current Year$112,360CurrentYearAmt
Total$493,768TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$740,652GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus2$58,081CurrentYearMinus2Amt
Current Year Minus1$40,551CurrentYearMinus1Amt
Current Year$37,091CurrentYearAmt
Total$135,723TotalAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp
CY Minus3 Yr Endwmt FundCYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt FundCYMinus4YrEndwmtFundGrp
LandLandGrp
BuildingsBuildingsGrp
Leasehold ImprovementsLeaseholdImprovementsGrp

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$151,380OtherCostOrOtherBasisAmt
Depreciation$109,367DepreciationAmt
Book Value$42,013BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$70,340OtherCostOrOtherBasisAmt
Depreciation$66,982DepreciationAmt
Book Value$3,358BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$45,371TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt
Total Liability$0TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$10,275,440TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$640,807NetUnrealizedGainsInvstAmt
Other Revenue$669,038OtherRevenueAmt
Revenue Not Reported$1,309,845RevenueNotReportedAmt
Revenue Subtotal$8,965,595RevenueSubtotalAmt
Total Revenue Per Form990$8,965,595TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$9,010,883TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$669,038OtherExpensesIncludedAmt
Expenses Not Reported$669,038ExpensesNotReportedAmt
Expenses Subtotal$8,341,845ExpensesSubtotalAmt
Total Expenses Per Form990$8,341,845TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE D, PART X, LINE 2:THE ORGANIZATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE ("IRC"), EXCEPT FOR NET INCOME DERIVED FROM UNRELATED BUSINESS ACTIVITIES. IN ADDITION, THE ORGANIZATION QUALIFIES FOR THE CHARITABLE CONTRIBUTION DEDUCTION UNDER SECTION 170(B)(1)(A) AND HAS BEEN CLASSIFIED AS AN ORGANIZATION OTHER THAN A PRIVATE FOUNDATION UNDER IRC SECTION 509(A). THE ORGANIZATION'S INCOME TAX FILINGS ARE SUBJECT TO AUDIT BY VARIOUS TAXING AUTHORITIES. IN EVALUATING THE ORGANIZATION'S ACTIVITIES, MANAGEMENT BELIEVES ITS POSITION OF TAX-EXEMPT STATUS IS BASED ON CURRENT FACTS AND CIRCUMSTANCES AND THERE HAVE BEEN NO UNCERTAIN POSITIONS TAKEN RELATED TO RECORDING INCOME TAXES. IT IS THE POLICY OF THE ORGANIZATION TO INCLUDE IN MANAGEMENT AND GENERAL EXPENSES PENALTIES AND INTEREST ASSESSED BY INCOME TAXING AUTHORITIES. THERE WERE NO PENALTIES FROM TAXING AUTHORITIES INCLUDED IN MANAGEMENT AND GENERAL EXPENSES FOR THE YEAR ENDED JUNE 30, 2021.
Schedule D, Part XI, Line 4b - Other AdjustmentsSpecial Events: $(538,529) Sale of Goods: $(130,509) Total: $(669,038)
Schedule D, Part XII, Line 2d - Other AdjustmentsSpecial Events: $538,529 Sale of Goods: $130,509 Total: $669,038

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp

FieldValueIRS element (for citing)
RegionEast Asia and the PacificRegionTxt
Offices0OfficesCnt
Employee0EmployeeCnt
Type Of Activities ConductedGrantmakingTypeOfActivitiesConductedTxt
Region Total Expenditures$50,000RegionTotalExpendituresAmt
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$50,000SubtotalSpentAmt
Total Spent$50,000TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionEast Asia and the PacificRegionTxt
Purpose Of GrantSee Part IVPurposeOfGrantTxt
Cash Grant$50,000CashGrantAmt
Manner Of Cash DisbursementWireMannerOfCashDisbursementTxt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Part I, Line 2For larger grants, the Organization requests semi-annual reports detailing the use of grant funds from the recipient organizations.
Part II, Line 1, COLUMN (D)1. TEL AVIV SOURASKY MEDICAL CENTER - PROJECT TITLE - SINGLE-CELL IMMUNOPHENOTYPING OF CHRONIC FIBROSING INTERSTITIAL LUNG DISEASES PULMONARY FIBROSIS (PF) IS A CHRONIC LUNG DISEASE THAT OCCURS WHEN LUNG TISSUE BECOMES DAMAGED AND SCARRED, MAKING BREATHING DIFFICULT. THERE ARE MANY TYPES OF PF WITH DIFFERENT CAUSES AND SEVERITY LEVELS. DETERMINING THE CORRECT DIAGNOSIS IS IMPORTANT FOR RISK ASSESSMENT AND TREATMENT DECISIONS; HOWEVER, IT MAY NECESSITATE A LUNG BIOPSY WHICH MAY BE RISKY. IN THIS RESEARCH PROJECT WE WILL USE A HIGHLY INNOVATIVE TECHNOLOGY CALLED "SINGLE-CELL PROFILING" WHICH ALLOWS THE RESEARCHERS TO LOOK AT CELLS, THE BUILDING BLOCKS OF OUR BODY, AT A HIGHER RESOLUTION THAN EVER BEFORE. WE WILL USE IT TO IDENTIFY SPECIFIC CHANGES IN THE IMMUNE SYSTEM IN THE BLOOD THAT REFLECT THE SPECIFIC CAUSE OF FIBROSIS IN THE LUNGS. SOME OF THESE CHANGES COULD LATER BE USED AS BIOMARKERS TO BETTER DIAGNOSE THE CAUSE OF PF, WITHOUT THE NEED FOR A LUNG BIOPSY. INSIGHTS FROM THIS RESEARCH WILL LEAD TO A BETTER UNDERSTANDING OF THE IMMUNE SYSTEM'S ROLE IN PF, FACILITATING THE DEVELOPMENT OF NEW TREATMENTS THAT ARE TAILORED TO THE SPECIFIC CAUSE OF PF IN AN INDIVIDUAL PATIENT.

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1PFF WALKSEvent1Nm
Gross Receipts Event1$684,791GrossReceiptsEvent1Amt
Charitable Contri Event1$684,791CharitableContriEvent1Amt
Other Direct Expenses Event1$341,175OtherDirectExpensesEvent1Amt
Event2BROADWAY BELTSEvent2Nm
Gross Receipts Event2$354,085GrossReceiptsEvent2Amt
Charitable Contri Event2$354,085CharitableContriEvent2Amt
Rent Facility Costs Event2$500RentFacilityCostsEvent2Amt
Food And Beverage Event2$3,911FoodAndBeverageEvent2Amt
Entertainment Event2$52EntertainmentEvent2Amt
Other Direct Expenses Event2$192,891OtherDirectExpensesEvent2Amt
Other Events Total0OtherEventsTotalCnt
Gross Receipts Total$1,038,876GrossReceiptsTotalAmt
Charitable Contributions Tot$1,038,876CharitableContributionsTotAmt
Rent Fclty Costs Total Events$500RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$3,911FoodAndBeverageTotalEventsAmt
Entertainment Total Events$52EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$534,066OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$538,529DirectExpenseSummaryEventsAmt
Net Income Summary-$538,529NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule G, Part II, Line 2:FormAndLineReferenceDesc
ExplanationAll events during FY20-21 were conducted virtually. Thus, all gross receipts are contributions.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
University of Vermont State & Agricultural College
85 S Prospect StBurlingtonVT05405030179440501(c)(3)$50,000See Part IV
Vanderbilt University Medical Center
3319 W End AveNashvilleTN372036856620476822501(c)(3)$50,000See Part IV
University of Pittsburgh
3420 Forbes AvePittsburghPA15260250965591501(c)(3)$50,000See Part IV
University of colorado Denver AMC and DC
13001 E 17th PlaceAuroraCO80045846000555501(c)(3)$50,000See Part IV
University of Pittsburgh
3420 Forbes AvePittsburghPA15260250965591501(c)(3)$50,000See Part IV
FieldValueIRS element (for citing)
Total501c3 Org5Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule I, Part I, Line 2For larger grants, the Organization requests semi-annual reports detailing the use of grant funds from the recipient organizations.
Schedule I, Part II, Line 1(h) Purpose of Grant1. THE UNIV OF VERMONT AND STATE AGRICULTURAL COLLEGE - PROJECT TITLE - COLLAGEN S-GLUTATHIONYLATION PROMOTES PULMONARY FIBROSIS THROUGH MYOFIBROBLAST ACTIVATION. HEALTHY HUMAN TISSUE IS DEVELOPED AND MAINTAINED BY TIGHTLY ORCHESTRATED INTERACTIONS BETWEEN CELLS AND THEIR ENVIRONMENT. ALTERATIONS IN THESE INTERACTIONS ARE KNOWN TO ACCOMMODATE OR LEAD TO DISEASE SUCH AS PULMONARY FIBROSIS. IN THE HUMAN LUNG, EPITHELIAL CELLS INTERACT WITH OTHER RESIDENT LUNG CELLS AND EXTRACELLULAR MATRIX TO PROPERLY PROVIDE A PROTECTIVE BARRIER OR SELECTIVE GAS EXCHANGE. HOWEVER, REPEATED DAMAGE TO THESE EPITHELIAL CELLS, WHETHER FROM GENETIC OR ENVIRONMENTAL ORIGINS, IS ASSOCIATED WITH THE DEVELOPMENT OF EXCESSIVE EXTRACELLULAR MATRIX (FIBROTIC SCARRING), ALTERED LUNG CELL IDENTITY AND IMPROPER INTERACTIONS BETWEEN CELLS. IN ADDITION TO THIS, OUR RESEARCH GROUP HAS DISCOVERED A LINK BETWEEN PULMONARY FIBROSIS AND ALTERED LUNG REDOX (REDUCTION/OXIDATION) STATES, SPECIFICALLY PROTEIN S-GLUTATHIONYLATION, PROVIDING A NEW WINDOW OF OPPORTUNITY FOR THERAPEUTIC INTERVENTION. THE RESEARCH GROUP IS THEREFORE STUDYING THE ROLES OF PROTEIN S-GLUTATHIONYLATION DURING THE PROCESSES OF EXCESSIVE EXTRACELLULAR MATRIX PRODUCTION, CELL DIFFERENTIATION AND CELL-TO-CELL COMMUNICATION IN THE LUNG, WITH THE GOAL OF RESOLVING FIBROTIC SCARRING AND ENABLING PROPER LUNG CELL FUNCTION.
Schedule I, Part II, Line 2(h) Purpose of Grant2. VANDERBILT UNIVERSITY MEDICAL CENTER - PROJECT TITLE - YAP/WNT INTERACTIONS REGULATE EPITHELIAL CELL PROLIFERATION AND DIFFERENITATION LEADING TO ABNORMAL REPAIR AND PROGRESSION OF IPF THE LUNG HAS A REMARKABLE CAPACITY TO REGENERATE AFTER INJURY. HOWEVER, FAILURE OF THESE REPAIR MECHANISMS CONTRIBUTES TO DEVELOPMENT OF DISEASES INCLUDING IDIOPATHIC PULMONARY FIBROSIS (IPF), A CHRONIC FORM OF INTERSTITIAL LUNG DISEASE WITH POOR PROGNOSIS DUE TO IRREVERSIBLE PROGRESSIVE ALVEOLAR DAMAGE RESULTING IN RESPIRATORY FAILURE AND FATALITY USUALLY WITHIN 2-5 YEARS OF DIAGNOSIS. RECENT WORK DEMONSTRATED THE WNT SIGNALING PATHWAY IS INVOLVED DURING NORMAL LUNG REGENERATION AND IS UPREGULATED IN IPF. OUR PREVIOUS WORK IDENTIFIED THE HIPPO/YAP PATHWAY AS BEING ABNORMALLY ACTIVATED IN IPF EPITHELIAL CELLS, AND OUR PRELIMINARY DATA SHOWS ABNORMAL ACTIVATION OF YAP RESULTS IN ABNORMALLY DIFFERENTIATED RESPIRATORY CELLS. PRELIMINARY STUDIES PREDICT THAT YAP AND WNT MAY INTERACT TO REGULATE THE NORMAL AND DISEASE STATE CELLS. THIS PROJECT AIMS TO DETERMINE THE ROLES OF YAP ACTIVITY DURING NORMAL AND PATHOGENETIC REPAIR PROCESSES AND HOW YAP ACTIVITY MAY BE MODULATED BY WNT SIGNALING.
Schedule I, Part II, Line 3(h) Purpose of Grant3. UNIVERSITY OF PITTSBURGH - PROJECT TITLE - AIR POLLUTION: CLINICAL OUTCOMES AND EPIGENOMIC EFFECTS IN INTERSTITIAL LUNG DISEASES AIR POLLUTION IS A MASSIVE GLOBAL PUBLIC HEALTH PROBLEM, LEADING TO AN ESTIMATED 8.9 MILLION PREMATURE DEATHS WORLDWIDE ANNUALLY. PATIENTS WITH CHRONIC RESPIRATORY DISEASES ARE ESPECIALLY VULNERABLE TO THE HARMFUL EFFECTS OF AIR POLLUTION. OUR UNDERSTANDING OF THE IMPACTS OF AIR POLLUTION IN PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASE (ILD) IS LIMITED. FIBROTIC ILDS REPRESENT A GROUP OF OVER 200 DISEASES CHARACTERIZED BY SHORTNESS OF BREATH, LUNG FUNCTION DECLINE, AND HIGH MORBIDITY AND MORTALITY. THE BURDEN OF FIBROTIC ILDS IS INCREASING WORLDWIDE AS IS OUR UNDERSTANDING OF HOW ENVIRONMENTAL FACTORS CONTRIBUTE TO THE DEVELOPMENT AND PROGRESSION OF THESE CONDITIONS. THIS STUDY WILL UTILIZE CLINICAL DATA COLLECTED THROUGH THE PULMONARY FIBROSIS FOUNDATION (PFF) REGISTRY OF PATIENTS WITH FIBROTIC ILD TO CLARIFY HOW AIR POLLUTION IMPACTS CLINICAL OUTCOMES IN THESE PATIENTS AND THE MOLECULAR MECHANISMS WHICH UNDERLY THESE EFFECTS. ENVIRONMENTAL FACTORS MAY AFFECT DISEASE BY CONTROLLING HOW GENES RESULT IN PROTEIN PRODUCTION WITHOUT CHANGING THE GENETIC CODE (ALSO KNOWN AS EPIGENETICS). DNA METHYLATION IS ONE THE MOST COMMON EPIGENETIC CHANGES THAT CAN OCCUR DUE TO ENVIRONMENTAL EXPOSURES SUCH AS AIR POLLUTION. WE WILL FIRST LOOK AT HOW AIR POLLUTION AFFECTS LUNG FUNCTION, HOSPITAL ADMISSION, AND DEATH IN PATIENTS WITH ILD. SUBSEQUENTLY, WE WILL USE PATIENT BLOOD SAMPLES COLLECTED BY THE PFF TO EVALUATE DNA METHYLATION. OUR STUDY AIMS TO INCREASE UNDERSTANDING OF HOW ENVIRONMENTAL FACTORS CONTRIBUTE TO ILD DEVELOPMENT AND PROGRESSION. THIS STUDY MAY FIND NEW TOOLS FOR MONITORING AIR POLLUTION AND DISEASE PROGRESSION, ALONGSIDE NEW TARGETS FOR TREATMENT TO IMPROVE THE LIVES OF PATIENTS WITH ILD.
Schedule I, Part II, Line 4(h) Purpose of Grant4. UNIV OF COLORADO DENVER, AMC AND DC - PROJECT TITLE - IMPROVING PATIENT AND CAREGIVER OUTCOMES IN PULMONARY FIBROSIS: A NOVEL, DYADIC ASSESSMENT OF CAREGIVER BURDEN INDIVIDUALS WITH PULMONARY FIBROSIS (PF) LIVE WITH INTRUSIVE, BOTHERSOME SYMPTOMS AND IMPAIRED QUALITY OF LIFE. CAREGIVERS OF INDIVIDUALS WITH PF CAN EXPERIENCE SIGNIFICANT PHYSICAL, SOCIAL AND EMOTION IMPACTS IN THEIR OWN LIVES AS A RESULT OF CAREGIVING, A CONCEPT TERMED CAREGIVER BURDEN. CURRENTLY, WE DO NOT KNOW IF CAREGIVER BURDEN IS A SIGNIFICANT PROBLEM FOR CAREGIVERS OF INDIVIDUALS WITH PF. IF CAREGIVER BURDEN IS PRESENT, WE DO NOT KNOW WHAT FACTORS ABOUT PF CONTRIBUTE TO CAREGIVER BURDEN OR WHAT THE IMPACT OF BURDEN IS FOR BOTH CAREGIVERS AND PATIENTS. AS NEITHER PATIENTS NOR CAREGIVERS EXIST IN ISOLATION, THIS PROPOSAL WILL EVALUATE PATIENTS AND THEIR CAREGIVERS TOGETHER, CALLED DYADS, TO FURTHER OUR UNDERSTANDING OF CAREGIVER BURDEN IN PF. ULTIMATELY, OUR LONG-TERM GOAL IS TO UTILIZE THIS INFORMATION TO LESSEN CAREGIVER BURDEN AND IMPROVE OUTCOMES, INCLUDING QUALITY OF LIFE, FOR BOTH PATIENTS AND THEIR CAREGIVERS.
Schedule I, Part II, Line 5(h) Purpose of Grant5. UNIVERSITY OF PITTSBURGH - PROJECT TITLE - INVESTIGATING THE MASTER REGULATORS OF MYOFIBROBLASTS IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE INTERSTITIAL LUNG DISEASE (ILD) IS THE LEADING CAUSE OF DEATH IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC), AN AUTOIMMUNE DISEASE RESULTING IN FIBROSIS OF THE SKIN, LUNGS, AND OTHER ORGANS. MYOFIBROBLASTS ARE THE KEY EFFECTOR CELL IN FIBROSIS DUE TO THEIR EXCESSIVE PRODUCTION OF COLLAGEN AND THEIR ACQUIRED CONTRACTILE CAPACITY; HOWEVER, NO TREATMENTS CURRENTLY EXIST TO TARGET THESE OVERACTIVE CELLS IN SSC-ILD OR OTHER ILDS. USING NOVEL TECHNOLOGY, WE ARE NOW ABLE TO ISOLATE INDIVIDUAL CELLS FROM THE LUNGS OF PATIENTS WITH SSC-ILD AT THE TIME OF LUNG TRANSPLANT AND STUDY THE RNA MOLECULES AND DNA STRUCTURE ENCODING FOR PROTEINS LIKE COLLAGEN, AS WELL AS ALL ACTIVE GENES IN THE CELL. UTILIZING THIS APPROACH, WE WILL DIRECTLY COMPARE THE RNA AND DNA STRUCTURE IN DISEASED MYOFIBROBLASTS WITH NORMAL FIBROBLASTS TO DETERMINE WHICH SPECIFIC TRANSCRIPTION FACTOR PROTEINS ARE OVERPRODUCED IN THE DISEASED FORM, THEN FURTHER EXAMINE THESE TRANSCRIPTION FACTORS AS POTENTIAL THERAPEUTIC TARGETS. THE DEVELOPMENT OF NEW MYOFIBROBLAST-DIRECTED THERAPIES HAS THE PROMISE OF PREVENTING DISEASE PROGRESSION TO RESPIRATORY FAILURE IN PATIENTS WITH SSC-ILD AND OTHER ILDS.

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Housing Allowance Or ResidenceYes (X)HousingAllowanceOrResidenceInd
Written Policy Ref T And E ExpnssfalseWrittenPolicyRefTAndEExpnssInd
Substantiation RequiredfalseSubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
William T Schmidt
Director/President and CEO$282,100$0$0$0$0$0$26,000$0$2,500$0$310,600$0$0$0
Scott Staszak
Chief Operating Officer$212,987$0$0$0$0$0$26,000$0$0$0$238,987$0$0$0
Laura Sadler
Chief Marketing Officer$185,556$0$500$0$0$0$0$0$6,794$0$192,850$0$0$0
Seth Klein
SENIOR VP, DEVELOPMENT$153,434$0$500$0$0$0$8,336$0$4,445$0$166,715$0$0$0
Kathryn TREBONSKY
VP, FINANCE THRU 04/01/21$135,389$0$500$0$0$0$9,752$0$16,896$0$162,537$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 1aCEO RESIDES IN MD AND CANNOT RELOCATE AT THIS TIME, HOWEVER, HE NEEDS TO SPEND SUBSTANTIAL TIME IN CHICAGO AND THEREFORE PFF AGREED TO PROVIDE A HOUSING ALLOWANCE.
Schedule J, Part I, Line 1bDETAILS ARE DISCLOSED IN CEO'S EMPLOYMENT CONTRACT. WE DO NOT OFFER THIS ARRANGEMENT TO OTHER STAFF MEMBERS AND THUS DO NOT HAVE A WRITTEN POLICY FOR A HOUSING ALLOWANCE. HOUSING ALLOWANCE ENDED DURING FY20-21.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (28 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
CONTINUED FROM FORM 990, PART III, LINE 4A:INDEPENDENTLY MANAGED BY A DATA COORDINATING CENTER. THE REGISTRY ALSO COLLECTS BIOLOGICAL SPECIMENS THAT PATIENTS HAVE AGREED TO GIVE, WHICH ARE DE-IDENTIFIED AND INDEPENDENTLY MANAGED BY A MEDICAL SPECIMEN STORAGE FACILITY ASSOCIATED WITH THE DATA COORDINATING CENTER. THE REGISTRY'S KEY AIMS ARE TO: (1) CONDUCT BENCHMARKING AND QUALITY IMPROVEMENT EFFORTS ACROSS THE PFF'S MEDICAL CENTER NETWORK; (2) DEVELOP A MORE REPRESENTATIVE UNDERSTANDING OF PF PATIENTS IN THE UNITED STATES; (3) FACILITATE RESEARCH IN IDENTIFIED PRIORITY AREAS; AND (4) INCREASE THE PFF'S REACH WITHIN THE PF COMMUNITY. AS OF JUNE 30, 2021, THE REGISTRY HAS ACTIVATED 42 SITES AND IDENTIFIED 2,003 PATIENTS FOR ENROLLMENT. THIS VITAL PROGRAM IS COMPLETING ITS FIRST PHASE AND WILL EMBARK ON THE NEXT PHASE TO CONTINUE TO CAPTURE CLINICAL PATIENT INFORMATION AND EXPAND INTO THE COMMUNITY TO COLLECT INFORMATION FROM OTHER PATIENTS, LUNG TRANSPLANT RECIPIENTS, CAREGIVERS, AND FAMILIES. THIS WILL PROVIDE A MORE REPRESENTATIVE UNDERSTANDING OF THE PF COMMUNITY AND CREATE A ROBUST POOL OF ENGAGED COMMUNITY MEMBERS FOR ADVOCACY, CLINICAL TRIALS, AND OTHER RESEARCH. TO LEARN MORE ABOUT THE PFF PATIENT REGISTRY, PLEASE GO TO: HTTPS://WWW.PULMONARYFIBROSIS.ORG/PFF-REGISTRY.
CONTINUED FROM FORM 990, PART III, LINE 4B:THE FOUNDATION DEVELOPED NEW EDUCATIONAL MATERIALS FOR PATIENTS WITH PF, THEIR CAREGIVERS, AND HEALTHCARE PROFESSIONALS IN FISCAL YEAR 2020-2021. THE PFF PRODUCED NEW PRINT MATERIALS IN ENGLISH AND SPANISH, INCLUDING THE "PREPARING FOR A LUNG TRANSPLANT" BOOKLET, THE "LIFE AFTER A LUNG TRANSPLANT" BOOKLET, AND THE "MEDICARE PATIENTS' OXYGEN RIGHTS" BROCHURE. THE PFF ALSO CREATED THE "RHEUMATOLOGY POCKET GUIDE" FOR HEALTHCARE PROVIDERS. ALL EDUCATIONAL DOCUMENTS ARE AVAILABLE AT PULMONARYFIBROSIS.ORG/ABOUT-US/WHAT-WE-DO/EDUCATION. THE PFF WORKED WITH THE AMERICAN ASSOCIATION OF CARDIOVASCULAR AND RESPIRATORY CARE TO CREATE A PULMONARY REHABILITATION TOOLKIT FOR PATIENTS. THE PULMONARY REHABILITATION TOOLKIT INCLUDES A SERIES OF EXERCISE VIDEOS, WORKSHEETS, AND INFORMATIONAL WEBINARS. THE PFF RELEASED SHORT VIDEOS AS PART OF A "MYTHS & MISCONCEPTIONS" SERIES. MISCONCEPTIONS INCLUDED TOPICS LIKE "NO ONE KNOWS WHAT CAUSES PULMONARY FIBROSIS"I HEARD OXYGEN IS ADDICTIVE & WILL WEAKEN MY LUNGS." THE PFF ALSO RELEASED SHORT VIDEOS HIGHLIGHTING TOP 5 PIECES OF INFORMATION FOR PF PATIENTS. THE PFF RELEASED A SUITE OF MATERIALS TO HELP PATIENTS NAVIGATE TELEMEDICINE, INCLUDING WEBINARS IN ENGLISH AND SPANISH, A TELEMEDICINE CHECKLIST FOR PF PATIENTS, A BOOKLET ON TELEMEDICINE FOR PF PATIENTS, AND A SURVEY OF PATIENTS' EXPERIENCE WITH TELEMEDICINE. IN FEBRUARY 2021, THE PFF CHANGED THE NAME OF THE PATIENT COMMUNICATION CENTER TO THE PFF HELP CENTER. THIS NAME REFLECTS THE BROAD RANGE OF INFORMATION AND RESOURCES THAT THE PFF HELP CENTER PROVIDES TO MEMBERS OF THE PF COMMUNITY. THE PFF WEBINAR SERIES ENGAGES THE PF COMMUNITY IN AN ONLINE WEBINAR DISCUSSION WHERE THEY LEARN FROM, CONNECT WITH, AND POSE QUESTIONS TO LEADING PULMONARY FIBROSIS SPECIALISTS. NINE WEBINARS WERE PRESENTED IN FISCAL YEAR 2020-21 AND ALL CAN BE VIEWED ON THE PFF WEBSITE AT HTTPS://BIT.LY/PFFWEBINARS AND ON THE FOUNDATION'S YOUTUBE CHANNEL. TOPICS ADDRESSED DURING THIS TIME PERIOD INCLUDE THE BENEFITS OF DIVERSITY IN RESEARCH, COVID-19, SYMPTOM MANAGEMENT, AND ACUTE EXACERBATIONS.
CONTINUED FROM FORM 990, PART III, LINE 4C:AND HEALTHCARE PROVIDERS TO SPOT SYMPTOMS EARLY FOR MORE ACCURATE, TIMELY DIAGNOSES. WE SHARPENED OUR MESSAGING FROM SIMPLY "KNOW THE SYMPTOMS" TO "EARLIER DIAGNOSIS." THE CAMPAIGN ROLLED OUT WITH A PRESS RELEASE AND REDESIGNED DIGITAL AND PRINT ADS DIRECTING AUDIENCES TO ABOUTPF.ORG.WE ALSO LAUNCHED A NEW SITE, ABOUTPF.ORG/ESPAOL, FOR MEMBERS OF THE HISPANIC POPULATION WHO MAY BE AT RISK FOR PF. OUR MEDIA RELATIONS EFFORT PRODUCED FEATURE STORIES ON RELEVANT TOPICS THROUGHOUT THE YEAR. WE KEPT PFF EXPERTS TOP-OF-MIND WITH TRADE MEDIA WITH CONTINUAL UPDATES ON TOPICS INCLUDING THE FIRST PATIENT ENROLLED IN PRECISION, PFF SCHOLARS PROGRAM, COVID-19 VACCINE STATEMENT, NEW PFF WEBSITE, AND MORE. PFF AMBASSADOR STORIES WERE HIGHLIGHTED IN NATIONWIDE MEDIA THROUGH COVERAGE ABOUT HILL DAY, PFF WALKS, AND TEAM PFF EVENTS. DURING PF AWARENESS MONTH, DR. SONYE DANOFF PARTICIPATED IN A HIGH-IMPACT RADIO MEDIA TOUR WHERE SHE DESCRIBED THE SYMPTOMS AND RISK FACTORS FOR PF. ENGLISH AND SPANISH DIGITAL ADS DROVE TRAFFIC TO THE ABOUTPF.ORG MICROSITES. PULMONARY FIBROSIS AWARENESS MONTH (SEPTEMBER) IS WHEN THE PF COMMUNITY UNITES AS A COLLECTIVE VOICE TO ENHANCE DISEASE AWARENESS AND PROVIDE OUTREACH TO THOSE IN NEED. DURING PULMONARY FIBROSIS AWARENESS MONTH, THE PF COMMUNITY JOINED THE PFF AND PARTICIPATED IN THE #BLUEUP4PF CAMPAIGN, ATTENDED VIRTUAL EDUCATIONAL AND TEAM PFF EVENTS, PARTICIPATED IN WEBINARS, AND SPREAD DISEASE AWARENESS THROUGH SOCIAL MEDIA. ALTHOUGH 2020 PRESENTED A PARTICULARLY DIFFICULT MEDIA ENVIRONMENT WITH HEALTH COVERAGE FOCUSED ON THE COVID-19 PANDEMIC, THESE ACTIVITIES OVERALL CONTINUED TO INCREASE AWARENESS OF PF AND ITS RISK FACTORS NATIONWIDE, GENERATING MORE THAN 370.2 MILLION IMPRESSIONS, AND SUCCESSFULLY GREW TRAFFIC TO THE ABOUTPF.ORG MICROSITES AND TO THE PFF'S WEBSITE, PULMONARYFIBROISIS.ORG. THE CAMPAIGN DROVE INQUIRIES TO THE PFF HELP CENTER. CONSTITUENCIES SERVED BY THE MARKETING CAMPAIGN INCLUDED PATIENTS AND POTENTIAL PATIENTS; CAREGIVERS AND FAMILIES; HEALTHCARE PROVIDERS; AND AT-RISK POPULATIONS. FOR MORE INFORMATION VISIT PULMONARYFIBROSIS.ORG/ABOUT-US/WHAT-WE-DO/PATIENT-SUPPORT-PROGRAMS.
FORM 990, PART III, LINE 4D:1. PFF CARE CENTER NETWORK: THE PULMONARY FIBROSIS FOUNDATION (PFF) IS DEDICATED TO PROMOTING EARLIER RECOGNITION AND DIAGNOSIS OF PULMONARY FIBROSIS AND ENSURING THAT PATIENTS RECEIVE THE HIGHEST QUALITY HEALTHCARE. AS PART OF THAT COMMITMENT, SINCE 2013 THE PFF HAS WORKED WITH THE PF MEDICAL COMMUNITY TO ESTABLISH AND EXPAND THE PFF CARE CENTER NETWORK (CCN) TO 68 CARE CENTERS WHERE PEOPLE WITH PF CAN FIND EXPERIENCED MEDICAL PROFESSIONALS WHO UNDERSTAND THEIR DISEASE AND SUPPORT SERVICES TO IMPROVE THE QUALITY OF THEIR LIVES. THE GOALS OF THE PFF CCN IS TO DELIVER STATE OF THE ART, PATIENT-CENTERED CARE; TO DISSEMINATE EDUCATION TO SUPPORT OUR PATIENTS, CAREGIVERS AND PROVIDERS; TO GIVE VOICE TO THE NEEDS OF OUR COMMUNITY THROUGH ADVOCACY AND FUNDRAISING; AND TO ACCELERATE RESEARCH IN PF BOTH DIRECTLY AND THROUGH COLLABORATIONS AND NETWORKING. 2. RESEARCH: THE PULMONARY FIBROSIS FOUNDATION (PFF) PLACES ENORMOUS IMPORTANCE ON CREATING AN ENVIRONMENT THAT WILL ASSIST IN THE DEVELOPMENT OF EFFECTIVE TREATMENTS FOR PULMONARY FIBROSIS (PF). IN ADDITION TO CREATING THE PFF PATIENT REGISTRY TO PROVIDE RESEARCHERS WITH DATA TO ADDRESS SPECIFIC RESEARCH QUESTIONS, WE ARE DIRECTLY FUNDING PF RESEARCH THROUGH THE PFF SCHOLARS PROGRAM, DEVELOPING LEGISLATIVE ADVOCACY EFFORTS, ENCOURAGING COLLABORATIVE RELATIONS BETWEEN INDUSTRY AND ACADEMIC RESEARCHERS, DELIVERING KEY COMMUNICATIONS TO PATIENTS, AND DEVELOPING SOLUTIONS TO BRIDGE EXISTING GAPS IN PF RESEARCH. THE PFF SCHOLARS PROGRAM SUPPORTS PROJECTS THAT OFFER A HIGH LIKELIHOOD OF IMPROVING THE UNDERSTANDING OF PF IN THE FOLLOWING RESEARCH AREAS: BASIC SCIENCE, TRANSLATIONAL, CLINICAL, EPIDEMIOLOGICAL, AND HEALTH SERVICES. THE GOAL OF THE PFF SCHOLARS PROGRAM IS TO SUPPORT EMERGING INVESTIGATORS TO ADVANCE RESEARCH THAT COULD TRANSLATE INTO SUCCESSFUL THERAPIES, WHILE ALSO ENABLING THESE PROMISING RESEARCHERS TO OBTAIN INDEPENDENT FUNDING AND CONTINUE THEIR CUTTING-EDGE RESEARCH. THE RESEARCH REVIEW COMMITTEE ADMINISTERS THE PEER-REVIEW PROCESS, WHICH IS COMPRISED OF 25 CREDIBLE EXPERTS FROM THE US AND CANADA. AFTER THEIR REVIEW AND RECOMMENDATIONS, THE PFF FUNDED SIX $50,000 GRANTS OVER A TWO YEAR PERIOD IN THE 2020 CYCLE. THE PFF ALSO CONSIDERS OTHER SMALLER GRANTS THAT FIT THE RESEARCH GUIDELINES. 3. OUTREACH AND AWARENESS: THE PFF AMBASSADOR PROGRAM EMPOWERS PATIENTS, CAREGIVERS, AND HEALTH CARE PROFESSIONALS AS SPOKESPERSONS FOR THE PF COMMUNITY ON BEHALF OF THE PFF. PFF AMBASSADORS PROMOTE DISEASE AWARENESS, PROVIDE UP-TO-DATE INFORMATION, AND OFFER HOPE AND INSPIRATION TO THOSE AFFECTED BY PULMONARY FIBROSIS. PFF AMBASSADORS ARE AVAILABLE TO SPEAK AT PFF CARE CENTER NETWORK EVENTS, SUPPORT GROUP MEETINGS, FUNDRAISING EVENTS, AND OTHER DISEASE AWARENESS AND EDUCATION PROGRAMS. PFF AMBASSADORS INCLUDE PATIENTS, CAREGIVERS, LUNG TRANSPLANT RECIPIENTS, AND FAMILY MEMBERS. IN NOVEMBER 2020, THE PFF HOSTED AN ONLINE VIRTUAL VOLUNTEER MEETING FOR VOLUNTEERS, INCLUDING PFF AMBASSADORS. THE PFF PROVIDES ONGOING TRAINING TO SUPPORT GROUP LEADERS THROUGHOUT THE YEAR. PULMONARY FIBROSIS AWARENESS MONTH (SEPTEMBER) IS WHEN THE PF COMMUNITY UNITES AS A COLLECTIVE VOICE TO ENHANCE DISEASE AWARENESS AND PROVIDE OUTREACH TO THOSE IN NEED. DURING PULMONARY FIBROSIS AWARENESS MONTH, THE PF COMMUNITY JOINED THE PFF AND PARTICIPATED IN THE #BLUEUP4PF CAMPAIGN, ATTENDED EDUCATIONAL EVENTS, HOSTED TEAM PFF FUNDRAISING EVENTS, PARTICIPATED IN WEBINARS AND SPREAD DISEASE AWARENESS THROUGH SOCIAL MEDIA. THE FOLLOWING PROGRAMMATIC SERVICE ACCOMPLISHMENTS ARE HIGHLIGHTED BELOW. THE PFF MEDICAL TEAM HAS DEVELOPED A NEW PFF CCN ANNUAL REPORT TO ALL 68 CARE CENTERS. THIS CENTER BASED REPORT WILL HAVE A STRONG EMPHASIS ON BENCHMARKING, RESEARCH, CLINICAL CARE, COMMUNITY-BASED CLINICAL SUPPORT, AND PATIENT SATISFACTION. WE ANTICIPATE THAT WITH THIS DATA CENTRIC APPROACH WE WILL BE BETTER POSITIONED TO UNDERSTAND THE UNIQUE CHARACTERISTICS WITHIN OUR NETWORK. THE PALLIATIVE CARE SERVICES IN CARE CENTERS SURVEY WORKING GROUP STRIVED FOR 100% CARE CENTER PARTICIPATION WITH AN ESTIMATED 136 SURVEY RESPONSES. THE AIMS OF THIS SURVEY IS TO UNDERSTAND THE ROLE OF PALLIATIVE CARE SERVICES, PERSPECTIVES AND CURRENT RESOURCES AVAILABLE TO PROVIDERS WHO CARE FOR PATIENTS WITH PULMONARY FIBROSIS AND INTERSTITIAL LUNG DISEASE. THE SURVEY WAS DISSEMINATED TO PHYSICIANS, ADVANCE PRACTICE PROVIDERS, NURSES, RESPIRATORY THERAPISTS, AND SOCIAL WORKERS WHO CARE FOR ILD PATIENTS AT THE 68 PFF CARE CENTERS. INTERSTITIAL LUNG DISEASE (ILD) CAUSES A PROFOUND SYMPTOM BURDEN AND CARRIES A HIGH MORTALITY. PALLIATIVE CARE IS DEDICATED TO IMPROVING QUALITY OF LIFE AND EMPOWERING PATIENTS IN ADVANCE CARE PLANNING. EARLY INTEGRATION OF PALLIATIVE CARE IN ILD IMPROVES THE RATES OF ADVANCE CARE PLANNING AND SYMPTOMATIC MANAGEMENT. KNOWLEDGE OF ILD PROVIDER PERSPECTIVES ON PALLIATIVE CARE IS KEY TO IMPROVING CARE DELIVERY TO ILD PATIENTS. DESCRIPTIVE STATISTICS WERE COMPILED FOR SURVEY RESPONSES FROM OCTOBER-DECEMBER 2020. THE SURVEY FOR PFF CARE CENTERS DURING THE 2020 COVID-19 PANDEMIC WAS CONDUCTED BY THE PFF CARE CENTER NETWORK. THE PURPOSE OF THIS SURVEY IS TO GATHER CENTER BASED INFORMATION ON THE IMPACT OF THE CORONAVIRUS DISEASE (COVID-19) BY DEVELOPING FUNCTIONING STRATEGIES FOR CLINICAL TRIAL NETWORKS IN THE EVENT OF THE NEXT SURGE OR OTHER EVENT MAKING PHYSICAL VISITS NOT POSSIBLE. THE RESULTS FROM THIS SURVEY WILL ONLY BE USED FOR ACADEMIC RESEARCH IN ORDER TO ALLOW THE PFF TO MOVE HEALTH INITIATIVES AND ADVOCACY RECOMMENDATIONS MEASURES FORWARD. WE UNDERSTAND THAT WE STILL HAVE MUCH WORK TO BE DONE, BUT WITH KEY RESEARCH INITIATIVES SUCH AS THESE WE WILL MAKE AN IMPACT IN PROMOTING EARLIER RECOGNITION AND DIAGNOSIS OF PULMONARY FIBROSIS AND ENSURING THAT PATIENTS RECEIVE THE HIGHEST QUALITY HEALTHCARE. 4. ADVOCACY: THE PFF ENGAGED POLICYMAKERS IN ADVOCATING FOR INCREASED FUNDING FOR PULMONARY FIBROSIS RESEARCH AND IMPROVED ACCESS TO OXYGEN FOR PATIENTS. THE PFF HOSTED A VIRTUAL HILL DAY IN MARCH TO ALLOW CONSTITUENTS TO SPEAK WITH THEIR MEMBERS OF CONGRESS ABOUT THE IMPACT OF PULMONARY FIBROSIS IN THEIR LIVES AND THE NEED FOR RESEARCH FUNDING. CONGRESS INCLUDED LANGUAGE ABOUT THE NEED FOR PULMONARY FIBROSIS RESEARCH IN THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE APPROPRIATIONS REPORT AND MAINTAINED PF AS AN ELIGIBLE TOPIC IN THE PEER REVIEWED MEDICAL RESEARCH PROGRAM. THE PFF ALSO JOINED OTHER PATIENT ADVOCACY AND PROFESSIONAL ORGANIZATIONS IN ADVOCATING FOR IMPROVED ACCESS TO PULMONARY REHABILITATION. THE CENTERS FOR MEDICARE & MEDICAID SERVICES INTRODUCED A FLEXIBILITY TO ALLOW FOR REIMBURSEMENT OF PULMONARY REHABILITATION VIA TELEHEALTH DURING THE COVID-19 PUBLIC HEALTH EMERGENCY.
5. PFF: PATIENT COMMUNICATION CENTER (PCC):THE PFF PATIENT COMMUNICATION CENTER (PCC) SERVES AS THE CENTRAL INFORMATION HUB FOR PULMONARY FIBROSIS PATIENTS, CAREGIVERS, THE SUPPORT GROUP LEADER NETWORK (SEE SUPPORT GROUP SECTION), AND HEALTH CARE PROFESSIONALS. THE PCC STAFF PROVIDES GENERAL INFORMATION ABOUT PULMONARY FIBROSIS THAT IS TAILORED TO INDIVIDUALS' NEEDS AND ANSWERS QUESTIONS ABOUT THE AVAILABILITY OF SUPPORT SERVICES AND OTHER ESSENTIAL RESOURCES. RESOURCES AVAILABLE INCLUDE: INFORMATION ON PFF PROGRAMS, EDUCATIONAL AND ADVOCACY MATERIALS, HOW TO FIND MEDICAL CARE AND SUPPORT GROUPS, ACCESS TO SUPPORT SERVICES, INFORMATION ABOUT AVAILABLE TREATMENTS, AND HOW TO FIND CLINICAL TRIALS. THE FOUNDATION CONTINUOUSLY SURVEYS THE PF COMMUNITY TO DETERMINE ADDITIONAL EDUCATIONAL MATERIALS OR TRANSLATIONS OF CURRENT MATERIALS THAT ARE NEEDED AND WORKS TO DEVELOP THOSE MATERIALS TO FIT UNMET NEEDS IN THE COMMUNITY. THE FOUNDATION ALSO FACILITATES PHYSICIAN EDUCATION BY PROVIDING MATERIALS THROUGH THE PATIENT COMMUNICATION CENTER AND AT EDUCATIONAL CONFERENCES. THE FOUNDATION MAINTAINS AN OXYGEN INFORMATION LINE TO PROVIDE PATIENTS AND CAREGIVERS WITH GENERAL INFORMATION ON ACCESSING AND SAFELY USING SUPPLEMENTAL OXYGEN. IN FISCAL YEAR 2019-2020, THE PATIENT COMMUNICATION CENTER RECEIVED 4,647 INQUIRIES VIA TELEPHONE AND EMAIL. 6. PFF SUMMIT: PFF SUMMIT 2021 IS THE PFF'S BIENNIAL INTERNATIONAL HEALTH CARE CONFERENCE ON PULMONARY FIBROSIS (PF). THE GOAL OF THE PFF SUMMIT IS TO FOSTER A COLLABORATIVE ENVIRONMENT TO IMPROVE EDUCATION AND AWARENESS OF PF AND TO IDENTIFY NEW APPROACHES TO TREAT, AND ULTIMATELY CURE, THIS DEVASTATING DISEASE. THE PFF SUMMIT FEATURES AN INNOVATIVE CONTINUING MEDICAL EDUCATION (CME) PROGRAM FOR HEALTH CARE PROFESSIONALS AND SESSIONS FOR PF PATIENTS AND CAREGIVERS THAT ADDRESS THEIR GROWING EDUCATIONAL NEEDS. (NOTE: SOME EXPENSES FOR THE PFF SUMMIT 2021 WERE INCLUDED IN THE 2019 FORM 990). 7. SUPPORT GROUPS: THE PFF SUPPORT GROUP LEADER NETWORK PROVIDES A FORUM FOR PF SUPPORT GROUP LEADERS TO CONNECT, EXCHANGE IDEAS, AND SHARE BEST PRACTICES. THE PFF'S SUPPORT GROUP NETWORK CONSISTS OF OVER 140 SUPPORT GROUPS ACROSS THE COUNTRY. THE PFF PROVIDES AN ONLINE PLATFORM FOR GROUPS TO USE TO MEET SAFELY DURING COVID-19. THE PFF PROVIDES PHONE-BASED SUPPORT GROUPS TO PATIENTS AND CAREGIVERS WHO DO NOT HAVE A LOCAL SUPPORT GROUP OR WOULD LIKE EXTRA SUPPORT. IN FISCAL YEAR 2020-21, THE PFF ADDED TWO NEW GROUPS (A GROUP FOR SPANISH SPEAKERS AND A GROUP FOR LUNG TRANSPLANT RECIPIENTS). THE PFF NOW HAS A TOTAL OF FOUR PHONE-BASED SUPPORT GROUPS. VISIT HTTP://BIT.LY/PFFSUPPORT TO LEARN MORE. IN NOVEMBER 2020, THE PFF HOSTED AN ONLINE VIRTUAL VOLUNTEER MEETING FOR VOLUNTEERS, INCLUDING SUPPORT GROUP LEADERS. THE PFF PROVIDES ONGOING TRAINING TO SUPPORT GROUP LEADERS THROUGHOUT THE YEAR AND THE COUNTRY. THE PFF PROVIDES AN ONLINE PLATFORM FOR GROUPS TO USE TO MEET SAFELY DURING COVID-19. THE PFF PROVIDES PHONE-BASED SUPPORT GROUPS TO PATIENTS AND CAREGIVERS WHO DO NOT HAVE A LOCAL SUPPORT GROUP OR WOULD LIKE EXTRA SUPPORT. IN FISCAL YEAR 2020-21, THE PFF ADDED TWO NEW GROUPS (A GROUP FOR SPANISH SPEAKERS AND A GROUP FOR LUNG TRANSPLANT RECIPIENTS). THE PFF NOW HAS A TOTAL OF FOUR PHONE-BASED SUPPORT GROUPS. VISIT HTTP://BIT.LY/PFFSUPPORT TO LEARN MORE. IN NOVEMBER 2020, THE PFF HOSTED AN ONLINE VIRTUAL VOLUNTEER MEETING FOR VOLUNTEERS, INCLUDING SUPPORT GROUP LEADERS. THE PFF PROVIDES ONGOING TRAINING TO SUPPORT GROUP LEADERS THROUGHOUT THE YEAR. FORM 990, PART VI, SECTION B, LINE 11B: A COPY OF FORM 990 IS REVIEWED BY THE FINANCE COMMITTEE BEFORE FILING. THE FORM 990 IS AVAILABLE TO ALL BOARD MEMBERS BEFORE FILING THE FORM.
FORM 990, PART VI, SECTION B, LINE 12C:THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY WITHIN THE EMPLOYEE HANDBOOK AND ALL EMPLOYEES ARE REQUIRED TO ADHERE TO THE POLICY. EMPLOYEES SIGN A DISCLOSURE FORM EACH YEAR. ANNUALLY, BOARD MEMBERS ARE SENT A FORM TO FILL OUT STATING WHETHER THEY HAVE ANY CONFLICTS OF INTEREST. IF SUCH CONFLICTS EXIST, THEN THEY FILL OUT AN ADDITIONAL FORM OUTLINING THOSE CONFLICTS. THE EXECUTIVE COMMITTEE REVIEWS ANY CONFLICTS THAT ARISE.
FORM 990, PART VI, SECTION B, LINES 15A & B:CHIEF EXECUTIVE OFFICER AND CHIEF OPERATING OFFICER'S COMPENSATION WAS APPROVED BY THE EXECUTIVE COMMITTEE, WHICH SERVES AS THE COMPENSATION COMMITTEE. THIS APPROVAL WAS BASED ON A REVIEW BY AN INDEPENDENT COMPENSATION CONSULTANT AND IS SUPPORTED BY A WRITTEN EMPLOYMENT CONTRACT. THE COMMITTEE ALSO REVIEWED COMPENSATION SURVEYS AND FORM 990S OF OTHER ORGANIZATIONS TO ENSURE THE COMPENSATION WAS APPROPRIATE. THE SALARY FOR THE CHIEF MARKETING OFFICER WAS NOT REVIEWED BY THE COMPENSATION COMMITTEE, BUT THE SALARY WAS IN LINE WITH THE MARKET.
FORM 990, PART VI, SECTION C, LINE 19:THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST AND ON THE ORGANIZATION'S WEBSITE. THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC.
FORM 990 PART IX LINE 11GDESCRIPTION:SITE PAYMENTS TOTAL FEES:747519
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY DCC CONSULTING TOTAL FEES:488144
FORM 990 PART IX LINE 11GDESCRIPTION:OTHER CONSULTATION TOTAL FEES:438857
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY CONSULTING TOTAL FEES:259615
FORM 990 PART IX LINE 11GDESCRIPTION:MARKETING CAMPAIGN CONSULTING TOTAL FEES:230532
FORM 990 PART IX LINE 11GDESCRIPTION:MARKETING CONSULTING TOTAL FEES:217999
FORM 990 PART IX LINE 11GDESCRIPTION:MEDICAL CONSULTING TOTAL FEES:186951
FORM 990 PART IX LINE 11GDESCRIPTION:RECRUITMENT FEES TOTAL FEES:90424
FORM 990 PART IX LINE 11GDESCRIPTION:OTHER OUTSIDE SERVICES TOTAL FEES:50532
FORM 990 PART IX LINE 11GDESCRIPTION:TRANSLATION SERVICES TOTAL FEES:41542
FORM 990 PART IX LINE 11GDESCRIPTION:MERCHANT CARD CHARGES TOTAL FEES:35928
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY HRCT CONSULTING TOTAL FEES:29641
FORM 990 PART IX LINE 11GDESCRIPTION:WRITING/EDITING TOTAL FEES:27850
FORM 990 PART IX LINE 11GDESCRIPTION:GRAPHIC DESIGN TOTAL FEES:25650
FORM 990 PART IX LINE 11GDESCRIPTION:MEDIA RELATIONS TOTAL FEES:14414
FORM 990 PART IX LINE 11GDESCRIPTION:EMPLOYEE ADMINISTRATION FEES TOTAL FEES:13988
FORM 990 PART IX LINE 11GDESCRIPTION:STIPENDS TOTAL FEES:8150
FORM 990 PART IX LINE 11GDESCRIPTION:IT CONSULTING TOTAL FEES:6137
FORM 990 PART IX LINE 11GDESCRIPTION:CME TOTAL FEES:4500
FORM 990 PART IX LINE 11GDESCRIPTION:PHOTOGRAPHY TOTAL FEES:1642

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.